409 related articles for article (PubMed ID: 22474602)
1. Synapses and dendritic spines as pathogenic targets in Alzheimer's disease.
Yu W; Lu B
Neural Plast; 2012; 2012():247150. PubMed ID: 22474602
[TBL] [Abstract][Full Text] [Related]
2. Synapse pathology in psychiatric and neurologic disease.
van Spronsen M; Hoogenraad CC
Curr Neurol Neurosci Rep; 2010 May; 10(3):207-14. PubMed ID: 20425036
[TBL] [Abstract][Full Text] [Related]
3. Dendritic spine loss and synaptic alterations in Alzheimer's disease.
Knobloch M; Mansuy IM
Mol Neurobiol; 2008 Feb; 37(1):73-82. PubMed ID: 18438727
[TBL] [Abstract][Full Text] [Related]
4. Dendritic spines are lost in clusters in Alzheimer's disease.
Mijalkov M; Volpe G; Fernaud-Espinosa I; DeFelipe J; Pereira JB; Merino-Serrais P
Sci Rep; 2021 Jun; 11(1):12350. PubMed ID: 34117272
[TBL] [Abstract][Full Text] [Related]
5. Amyloid beta: a putative intra-spinal microtubule-depolymerizer to induce synapse-loss or dentritic spine shortening in Alzheimer's disease.
Mitsuyama F; Futatsugi Y; Okuya M; Karagiozov K; Peev N; Kato Y; Kanno T; Sano H; Koide T
Ital J Anat Embryol; 2009; 114(2-3):109-20. PubMed ID: 20198823
[TBL] [Abstract][Full Text] [Related]
6. Spines, plasticity, and cognition in Alzheimer's model mice.
Spires-Jones T; Knafo S
Neural Plast; 2012; 2012():319836. PubMed ID: 22203915
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.
Chabrier MA; Cheng D; Castello NA; Green KN; LaFerla FM
Neurobiol Dis; 2014 Apr; 64():107-17. PubMed ID: 24440055
[TBL] [Abstract][Full Text] [Related]
8. Thin, stubby or mushroom: spine pathology in Alzheimer's disease.
Tackenberg C; Ghori A; Brandt R
Curr Alzheimer Res; 2009 Jun; 6(3):261-8. PubMed ID: 19519307
[TBL] [Abstract][Full Text] [Related]
9. The Accumulation of Tau in Postsynaptic Structures: A Common Feature in Multiple Neurodegenerative Diseases?
Teravskis PJ; Ashe KH; Liao D
Neuroscientist; 2020; 26(5-6):503-520. PubMed ID: 32389059
[TBL] [Abstract][Full Text] [Related]
10. L-3-n-Butylphthalide improves synaptic and dendritic spine plasticity and ameliorates neurite pathology in Alzheimer's disease mouse model and cultured hippocampal neurons.
Huang L; Lan J; Tang J; Kang Y; Feng X; Wu L; Peng Y
Mol Neurobiol; 2021 Mar; 58(3):1260-1274. PubMed ID: 33146400
[TBL] [Abstract][Full Text] [Related]
11. Region-specific dendritic simplification induced by Aβ, mediated by tau via dysregulation of microtubule dynamics: a mechanistic distinct event from other neurodegenerative processes.
Golovyashkina N; Penazzi L; Ballatore C; Smith AB; Bakota L; Brandt R
Mol Neurodegener; 2015 Nov; 10():60. PubMed ID: 26541821
[TBL] [Abstract][Full Text] [Related]
12. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
[TBL] [Abstract][Full Text] [Related]
13. Synaptic Plasticity, Dementia and Alzheimer Disease.
Skaper SD; Facci L; Zusso M; Giusti P
CNS Neurol Disord Drug Targets; 2017; 16(3):220-233. PubMed ID: 28088900
[TBL] [Abstract][Full Text] [Related]
14. Synaptic changes in Alzheimer's disease and its models.
Pozueta J; Lefort R; Shelanski ML
Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952
[TBL] [Abstract][Full Text] [Related]
15. Analyzing dendritic spine pathology in Alzheimer's disease: problems and opportunities.
Dorostkar MM; Zou C; Blazquez-Llorca L; Herms J
Acta Neuropathol; 2015 Jul; 130(1):1-19. PubMed ID: 26063233
[TBL] [Abstract][Full Text] [Related]
16. Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease.
Penzes P; Vanleeuwen JE
Brain Res Rev; 2011 Jun; 67(1-2):184-92. PubMed ID: 21276817
[TBL] [Abstract][Full Text] [Related]
17. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
18. The upside of APP at synapses.
Hoe HS; Lee HK; Pak DT
CNS Neurosci Ther; 2012 Jan; 18(1):47-56. PubMed ID: 21199446
[TBL] [Abstract][Full Text] [Related]
19. Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology.
Price KA; Varghese M; Sowa A; Yuk F; Brautigam H; Ehrlich ME; Dickstein DL
Mol Neurodegener; 2014 Oct; 9():41. PubMed ID: 25312309
[TBL] [Abstract][Full Text] [Related]
20. Synaptic tau: A pathological or physiological phenomenon?
Robbins M; Clayton E; Kaminski Schierle GS
Acta Neuropathol Commun; 2021 Sep; 9(1):149. PubMed ID: 34503576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
